Eli Lilly Braces for Reorganization Moves

The latest re-org announcement is from Eli Lilly (LLY). The company is getting braced for the Zyprexa patent expiration (and the possibility that Prasugrel and others won't be able to make up for as much lost revenue as they thought). Their target is a 14% head count reduction by the end of 2011.

For everyone's sake there, if they're really going to do that, I hope they do it quickly. Having that sort of thing hanging around over everyone's head is, to put it mildly, not good for anyone's quality of life (whether they're being let go or not). I haven't heard how these cuts will be distributed (across research, sales, administrative, etc.), but I suspect that details will start leaking out soon.

Comments

[Daniel Mark...:]

Eli Lilly has received a huge criminal fine over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,liti...
We put Lilly products in our babies they really need to clean up their act and quit with the white wash.
Eli Lilly Zyprexa can cause diabetes
I took Zyprexa a powerful Lilly schizophrenic drug for 4 years it was prescribed to me off-label for post traumatic stress disorder was ineffective costly and gave me diabetes.
This is a powerful drug that can damage a young person physiologically for life.
Please take with caution and learn as much as you can about side effects.
Daniel Haszard www.zyprexa-victims.com

Sep 16 03:26 AM

[Justin M. Hall:]

Daniel: PTSD? I was unaware that docs prescribed Zyprexa off-label for PTSD. From my understanding, treating physicians typically start with various anti-depressants. Interesting.

Mr. Lowe:

Since I am from Indianapolis and have friends who work for (LLY), I share your sentiment.

What are your thoughts on LLY's chief executive, if any?

Justin M. Hall

Sep 16 05:16 AM